1HBT
Human alpha-thrombin complexed with a peptidyl pyridinium methyl ketone containing bivalent inhibitor
1HBT の概要
| エントリーDOI | 10.2210/pdb1hbt/pdb |
| 分子名称 | ALPHA-THROMBIN (SMALL SUBUNIT), ALPHA-THROMBIN (LARGE SUBUNIT), P596 Inhibitor peptide, ... (4 entities in total) |
| 機能のキーワード | serine protease, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| 細胞内の位置 | Secreted, extracellular space: P00734 P00734 |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 35993.08 |
| 構造登録者 | |
| 主引用文献 | Rehse, P.H.,Steinmetzer, T.,Li, Y.,Konishi, Y.,Cygler, M. Crystal structure of a peptidyl pyridinium methyl ketone inhibitor with thrombin. Biochemistry, 34:11537-11544, 1995 Cited by PubMed Abstract: The crystal structure of a complex between a bivalent peptidyl pyridinium methyl ketone inhibitor and human alpha-thrombin has been solved and refined at 2.0 A to an R factor of 0.18. The inhibitor, (D)cyclohexylalanine-Pro-Arg-(CH2N+C5H4CH2CO)-(Gly)4-Asp- Tyr-Glu-Pro-Ile-Pro-Glu-Glu-Ala-cyclo-hexylalanine-(D)Glu (coded P596), which forms a reversible covalent complex with thrombin, is highly potent with a Ki = 4.6 +/- 1.0 x 10(-14) M, lower than that of recombinant hirudin. The N-terminal, active-site-directed portion of the inhibitor is linked to the fibrinogen recognition exosite binding portion by a tetraglycine segment. The strong electron-withdrawing effect provided by the permanent positive charge on the pyridinium nitrogen makes the arginyl carbonyl carbon more susceptible to nucleophilic attack. In the crystal, a covalent P596-thrombin complex is observed. The electron density surrounding the active site portion and the pyridinium of the inhibitor is very well defined, clearly showing the existence of a covalent bond between the Ser195 O gamma and the now tetrahedral carbon of the inhibitor. The decreased binding ability of thrombin inhibitors containing N-terminal acetylation is discussed as is the effect of replacing the P3 (D)phenylalanine with (D)cyclohexylalanine. The electron density surrounding the remainder of the inhibitor is generally well defined, the exceptions being the C-terminal (D)Glu, the highly flexible tetraglycine linker, and some of the solvent-directed side chains.(ABSTRACT TRUNCATED AT 250 WORDS) PubMed: 7547884DOI: 10.1021/bi00036a029 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






